InsiderClue
Insiders · Profile

Tulipano Stephen J

CFO at Stoke Therapeutics · Chief Financial Officer at Aldeyra Therapeutics. Filing since 17 Feb 2017. CIK 0001360548

STOK Stoke Therapeutics, Inc. CFO · 6 trades ALDX Aldeyra Therapeutics, Inc. Chief Financial Officer · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
STOK Stoke Therapeutics, Inc.
19 Mar 2024
CFO
Sold at will
4,116
$25.10K
16.6%
STOK Stoke Therapeutics, Inc.
23 Feb 2021
CFO
Sold, plan not stated
5,000
$292.99K
89.3%
STOK Stoke Therapeutics, Inc.
22 Feb 2021
CFO
Sold, plan not stated
25,000
$1.47M
97.6%
STOK Stoke Therapeutics, Inc.
4 Nov 2020
CFO
Sold, plan not stated
33,268
$1.36M
98.2%
STOK Stoke Therapeutics, Inc.
3 Nov 2020
CFO
Sold, plan not stated
1,732
$69.00K
74.2%
STOK Stoke Therapeutics, Inc.
2 Nov 2020
CFO
Sold, plan not stated
35,000
$1.30M
98.3%
ALDX Aldeyra Therapeutics, Inc.
17 Feb 2017
Chief Financial Officer
Bought
3,333
$15.00K
opened
7 decisions on file.